| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/07/1996 | EP0724588A1 Drug binding protein |
| 08/07/1996 | EP0724456A1 Antibodies to cd40 |
| 08/07/1996 | EP0724455A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 08/07/1996 | EP0527813B1 T-CEL LYMPHOMA cDNA CLONES |
| 08/07/1996 | CA2168827A1 Glycoproteins, process for preparation thereof, and pharmaceutical composition |
| 08/06/1996 | US5543503 Antiinflammatory agents |
| 08/06/1996 | US5543499 Genetic engineering |
| 08/06/1996 | US5543497 Effects removal of the phthalyl group from a phthalamide-blocked amine; protection of amine groups in the synthesis of antibiotics, e.g. carbocephalosporins, and peptides |
| 08/06/1996 | US5543320 Genetic engineering |
| 08/06/1996 | US5543140 Method and use of IL-1α |
| 08/01/1996 | WO1996023226A1 Immunoenzymatic conjugate, preparation method therefor and uses thereof |
| 08/01/1996 | WO1996023225A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 08/01/1996 | WO1996023073A1 Dna integration by transposition |
| 08/01/1996 | WO1996023071A2 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY |
| 08/01/1996 | WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 08/01/1996 | WO1996023067A1 Human interleukin-1 receptor accessory protein |
| 08/01/1996 | WO1996023066A2 Prostaglandin receptor, dp |
| 08/01/1996 | WO1996023063A1 Method of producing and purifying enzymes |
| 08/01/1996 | WO1996023000A1 Ligands for eph-like receptors |
| 08/01/1996 | WO1996022790A1 Composition to ameliorate osteolysis and metastasis |
| 08/01/1996 | WO1996022788A1 LYMPHOTOXIN-α/β COMPLEXES AND ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS |
| 08/01/1996 | WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof |
| 08/01/1996 | WO1996015231A3 Method for producing biologicals in protein-free culture |
| 08/01/1996 | WO1996013592A3 Protein kinase npk-110 |
| 08/01/1996 | WO1995031545A3 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein |
| 08/01/1996 | CA2211443A1 Lymphotoxin-.alpha./.beta. complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 08/01/1996 | CA2211176A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 08/01/1996 | CA2210724A1 Human interleukin-1 receptor accessory protein |
| 08/01/1996 | CA2210644A1 Ligands for eph-like receptors |
| 08/01/1996 | CA2210419A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy |
| 07/31/1996 | EP0723664A1 Detection and treatment of breast and gynecological cancer |
| 07/31/1996 | EP0723663A1 Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods |
| 07/31/1996 | EP0723595A1 A novel nuclear mitotic phosphoprotein: mitosin |
| 07/31/1996 | EP0723589A1 Novel trypanosoma cruzi antigen, and gene coding therefor; their application to the detection of chagas' disease |
| 07/31/1996 | EP0723588A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family |
| 07/31/1996 | EP0723587A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 07/31/1996 | EP0723585A1 Customized proteases |
| 07/31/1996 | EP0723556A1 Fas antagonists and uses thereof |
| 07/31/1996 | EP0723555A1 Chimeric proteins which block complement activation |
| 07/31/1996 | EP0723536A1 An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing |
| 07/31/1996 | EP0723455A1 Methods of inhibiting phagocytosis |
| 07/31/1996 | EP0723453A1 Method of treating reproductive disorders |
| 07/31/1996 | EP0723402A1 Senescent cell-derived inhibitors of dna synthesis |
| 07/31/1996 | EP0550665B1 Novel neurothrophic factor |
| 07/31/1996 | EP0491849B1 A method for the purification of transforming growth factor (tgf-) |
| 07/31/1996 | EP0471754B1 Production of vascular endothelial cell growth factor and dna encoding same |
| 07/31/1996 | EP0469074B1 Cysteine added variants il-3 and chemical modifications thereof |
| 07/31/1996 | EP0469060B1 Autoantibodies which enhance the rate of a chemical reaction |
| 07/31/1996 | EP0422175B1 Proteins which regulate the expression of vertebrate mhc class ii genes, dna sequences encoding them and pharmaceutical compositions |
| 07/31/1996 | CN1128047A Recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 07/31/1996 | CN1128046A Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 07/31/1996 | CN1032426C Glycopeptide recovery process |
| 07/31/1996 | CN1032425C Production of proteins in active forms |
| 07/30/1996 | US5541312 Production of interferon |
| 07/30/1996 | US5541298 Method of determining metastatic potential of tumor cells |
| 07/30/1996 | US5541293 Consensus human leukocyte interferon |
| 07/30/1996 | US5541291 Polypeptides |
| 07/30/1996 | US5541288 Peptide having elastase inhibitory activity and producing method thereof |
| 07/30/1996 | US5541160 Echinocandins |
| 07/30/1996 | US5541110 Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica |
| 07/30/1996 | US5541104 Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1 |
| 07/30/1996 | US5541101 Anti-oxytocin receptor antibodies |
| 07/30/1996 | US5541087 Expression and export technology of proteins as immunofusins |
| 07/30/1996 | US5541085 Method for preparing orphan receptor ligands |
| 07/30/1996 | US5541078 Antigenic peptide sequence of echinococcus granulosus and diagnostic applications |
| 07/30/1996 | US5541077 Fungal stress proteins |
| 07/30/1996 | US5541073 Method of diagnosing epidermis differentiation disorders in a patient using a stratum corneum-specific antibody |
| 07/30/1996 | US5541059 Immunoassay device having an internal control of protein A and methods of using same |
| 07/30/1996 | US5540926 Gp39 protein |
| 07/30/1996 | US5540923 Antiviral, antitumor, from trophoblast cells |
| 07/30/1996 | CA1338501C Method of detecting antibody against htlv-iii |
| 07/25/1996 | WO1996022386A1 A method for screening for inhibition of periplasmic oxidoreductase enzymes |
| 07/25/1996 | WO1996022384A1 Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
| 07/25/1996 | WO1996022377A1 Activation of t-cells by modified, antigenic immunoglobulins |
| 07/25/1996 | WO1996022374A1 A new chemokine expressed in fetal spleen, its production and uses |
| 07/25/1996 | WO1996022373A2 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/25/1996 | WO1996022371A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2 |
| 07/25/1996 | WO1996022369A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/25/1996 | WO1996022309A1 Anti-tpo monoclonal antibody |
| 07/25/1996 | WO1996022301A1 HETEROLOGOUS POLYPEPTIDE PRODUCTION IN THE ABSENCE OF NONSENSE-MEDIATED mRNA DECAY FUNCTION |
| 07/25/1996 | CA2210997A1 Activation of t-cells by modified, antigenic immunoglobulins |
| 07/25/1996 | CA2210683A1 Anti-tpo monoclonal antibodies |
| 07/25/1996 | CA2210560A1 Heterologous polypeptide production in the absence of nonsense-mediated mrna decay function |
| 07/25/1996 | CA2210158A1 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/25/1996 | CA2207086A1 G protein-coupled receptor gene |
| 07/25/1996 | CA2207009A1 A new chemokine expressed in fetal spleen, its production and uses |
| 07/24/1996 | EP0723014A2 cDNA of DOCK180 gene and DOCK180 protein |
| 07/24/1996 | EP0723013A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/24/1996 | EP0722951A2 Method and apparatus for the production of TGF-beta and purified TGF-beta compositions |
| 07/24/1996 | EP0722499A1 Immunoreactive antigens of hepatitis e virus |
| 07/24/1996 | EP0722495A1 A method for displaying proteins |
| 07/24/1996 | EP0722489A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 07/24/1996 | EP0722463A1 Methods and composition for the modulation of host immune response to allergens |
| 07/24/1996 | EP0722462A1 Dna encoding prostaglandin receptor ip |
| 07/24/1996 | EP0722461A1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences |
| 07/24/1996 | EP0722452A1 Nf-at polypeptides and polynucleotides |
| 07/24/1996 | EP0722339A1 $i(VIBRIO CHOLERAE) 01 (CVD111) AND NON-01 (CVD112 AND CVD112RM) SEROGROUP VACCINE STRAINS AND METHODS OF MAKING SAME |
| 07/24/1996 | EP0722337A1 Cd8?+ cell antiviral factor |
| 07/24/1996 | EP0722275A1 Cell death regulator |
| 07/24/1996 | EP0666905A4 Molecules with antibody combining sites that induce asymmetry. |